Company / Net Debt per Share
GeneDx Holdings Corp. Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.80
FY2025
5-year range
-$3141685.48 / -$1.13
FY2021-FY2025
Trend
-58.8%
vs FY2024
Sector context
#84 of 100
Health Care
What the data says
GeneDx Holdings Corp.'s net debt per share of $-1.80 is lower than 84% of companies in the Health Care sector (FY2025). Increased from $-3.69 to $-1.80 over the past 2 years.
Based on SEC 10-K filings.
-1.80 in FY2025.
Increased from $-3.69 to $-1.80 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 100This company -$1.80 Sector average $7.44
▼
-124.2% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 58.8% year-over-year.
- Ranks #84 out of 100 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2024.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.80 | -58.8% |
| FY2024 | -$1.13 | +69.3% |
| FY2023 | -$3.69 | +100.0% |
| FY2022 | -$22009.94 | +99.3% |
| FY2021 | -$3141685.48 | -17979.6% |
| FY2020 | -$17376.92 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026